PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31705883-8	2020	Comparisons of PLGF, sFLT-1 and sFLT-1/PLGF ratio in MoM values between the two groups of chronic hypertension and the controls were made by the ANOVA or the Kruskal-Wallis test.	Molybdenum	53-56	placental growth factor	Homo sapiens	39-43	
31705883-9	2020	RESULTS: In the group of chronic hypertension that developed preeclampsia, compared to those that did not develop preeclampsia, there were significantly lower median concentrations of serum PLGF MoM (0.904, interquartile range (IQR) 0.771-1.052 vs. 0.948, IQR 0.814-1.093; p=0.014) and sFLT-1 MoM (0.895, IQR 0.760-1.033 vs 0.938, IQR 0.807-1.095; p=0.013) and they were both lower than in the normotensive controls (1.009, IQR 0.901-1.111 and 0.991, IQR 0.861-1.159, respectively; P<0.01 for both).	Molybdenum	195-198	placental growth factor	Homo sapiens	190-194	
31589866-15	2019	In pregnancies with preterm PE, the mean MoM values of MAP and UtA-PI were significantly higher (MAP: 1.099 vs. 1.008; p<0.001; UtA-PI: 1.188 vs 1.063; p=0.006), and the mean PlGF MoM was significantly lower (0.760 vs. 1.100; p<0.001) than in women without PE.	Molybdenum	41-44	placental growth factor	Homo sapiens	178-182